Astellas tries again for telavancin in the EU
This article was originally published in Scrip
Executive Summary
Astellas has filed for the approval of telavancin in the EU for the treatment of nosocomial (hospital-acquired) pneumonia, including ventilator-assisted pneumonia, and adult complicated skin and soft tissue infections.